Plasma PAF-acetylhydrolase activity, inflammatory markers and susceptibility of LDL to in vitro oxidation in patients with type 1 diabetes mellitus

dc.creatorGomes, Marilia Brito
dc.creatorCobas, Roberta Arnold
dc.creatorNunes, Edson
dc.creatorFaria Neto, Hugo Caire de Castro
dc.creatorMatta, Maria Fátima Bevilacqua da
dc.creatorNeves, Ricardo
dc.creatorTibiriçá, Eduardo
dc.date2019-01-03T13:43:53Z
dc.date2019-01-03T13:43:53Z
dc.date2009
dc.date.accessioned2023-09-26T20:15:15Z
dc.date.available2023-09-26T20:15:15Z
dc.identifierGOMES, Marilia Brito; et al. Plasma PAF-acetylhydrolase activity, inflammatory markers and susceptibility of LDL to in vitro oxidation in patients with type 1 diabetes mellitus. Diabetes Research and Clinical Paractice, v.85, p.61-68, May 2009.
dc.identifier0168-8227
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/30851
dc.identifier10.1016/j.diabres.2009.04.016
dc.identifier1872-8227
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8852550
dc.descriptionWe evaluated if type 1 diabetic patients have altered levels of low-grade inflammatory markers including platelet-activating factor acetylhydrolase (PAF-AH) activity, high-sensitivity C-reactive protein (hs-CRP), white blood cells count (WBC), erythrocyte sedimentation rate (ESR) and LDL-cholesterol oxidation coefficient (OxC), and whether their levels are related to clinical complications and the metabolic profile.
dc.description2030-01-01
dc.formatapplication/pdf
dc.languageeng
dc.publisherElsevier
dc.rightsrestricted access
dc.subjectDiabetes tipo 1
dc.subjectMarcadores Inflamatórios
dc.subjectComplicações crônicas
dc.subjectEstresse oxidativo
dc.subjectInflammatory markers
dc.subjectOxidative stress
dc.subjectType 1 diabetes
dc.subjectChronic complications
dc.titlePlasma PAF-acetylhydrolase activity, inflammatory markers and susceptibility of LDL to in vitro oxidation in patients with type 1 diabetes mellitus
dc.typeArticle


Este ítem pertenece a la siguiente institución